An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical trial. Source: EU Clinical Trials Register
Indication of whether the sponsor is commercial or non-commercial. Source: EU Clinical Trials Register
Designation of orphan drug status to drugs that are in the process of development for the treatment of rare diseases. Source: EU Clinical Trials Register
A trial in which two or more treatments are evaluated concurrently in separate groups of patients. Source: EU Clinical Trials Register
Document upon which the development and authorisation of medicinal products for the paediatric population is based. It is presented by an applicant early during the development of a product to the EMA Paediatric Committee in order to agree a paediatric …
A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage. Source: EU Clinical Trials Register
Pharmacodynamics is the exploration of what the Medicinal Product does to the body. Source: EU Clinical Trials Register
Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. Source: EU Clinical Trials Register
Pharmacogenetics is generally regarded as the study or clinical trial of genetic variation that gives rise to differing response to drugs. Source: EU Clinical Trials Register
Pharmacogenomics is the broader application of genomic technologies to new drug discovery and further characterization of older drugs. Source: EU Clinical Trials Register